Oncoinvent
Oncoinvent AS is a privately held Norwegian company that designs and develops cancer treatments by applying known physical and chemical principles of selected novel materials in new ways in order to maximize their medical benefit while minimizing potential safety concerns
Oncoinvent has raised €3.7M across 1 funding round from 1 investor, most recently a Early VC round in May 2020. Based in Oslo, Norway; founded 2010; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€3.7M
€3,671,645
Funding rounds
1
Investors
1
distinct backers
Active since
2020-05
latest 2020-05
Funding by year
EUR raised per yearOncoinvent — funding by year — interactive chart.
Data table
| Oncoinvent — funding by year | |
|---|---|
| 2020 | €3.7M |
Signals
High confidenceRaise-next likelihood8
base rate 42% for Early VC
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-05-27 | Early VC | €3.7M | Hadean Ventures | View deal → |
Investors
1Related news
Similar companies
same sector or country- Visma€3.0BNorway · Software
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Adevinta€1.9BNorway · Marketing
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
Global coverage: FundingData